Evidence map›Paper›PMID 41601809›Full record

ArticleFrontiers in medicine2025

Comparison of two swept-source optical biometers in eyes with long axial length.

Pedro Tañá-Rivero, Paz Orts-Vila, Pedro Tañá-Sanz, Santiago Tañá-Sanz, Juan Álvarez de Toledo

Abstract read
In one paragraph

Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Pedro Tañá-RiveroOftalvist, Alicante, Spain.
Paz Orts-VilaOftalvist, Alicante, Spain.
Pedro Tañá-SanzOftalvist, Alicante, Spain.
Santiago Tañá-SanzOftalvist, Alicante, Spain.
Juan Álvarez de ToledoOftalvist, Barcelona, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: To assess the repeatability and agreement of two swept-source optical coherence tomography (SS-OCT)-based biometers when measuring biometric parameters in cataract eyes with a long axial length. Design: Cross-sectional prospective, comparative study. Methods: One-hundred and twenty-six eyes of 126 patients with cataracts (LOCS III grade equal or less than 3) and axial lengths >25 mm were measured 3 consecutive times using the Argos and IOLMaster 700 SS-OCT optical biometers. Keratometry [K1 (flat) and K2 (steep)], central corneal thickness (CCT), white-to-white (WTW), anterior-chamber-depth (ACD), lens-thickness (LT), and axial length were measured using both instruments. The repeatability for each device was analysed with the within-subject standard deviation (Sw), coefficient of variability, and coefficient of repeatability, and the agreement between the devices was analysed using a Bland-Altman plot. Results: The acquisition success rate for both biometers was 100%. For K1 and K2, the Sw values were <0.15D and <0.2D, respectively using the two instruments. For CCT, WTW, ACD and LT, the values were 6.56 μm, 0.05 mm, 0.01 mm and 0.01 mm with the Argos, and 3.54 μm, 0.07 mm, 0.01 mm and 0.01 mm with the IOLMaster 700. The Sw values for axial length were 0.01 and 0.03 mm for the Argos and IOLMaster 700, respectively. There were statistically significant differences between the two SS-OCT biometers for all the parameters evaluated ( Conclusion: Both SS-OCT biometers provide repeatable measurements for the different parameters analysed, however, when compared, it is clear that some of them must be assessed carefully in order to be considered interchangeable.

Indexed as

biometrycataractslong axial lengthopticaloptical coherence tomography

Identifiers

PMID41601809
PMCPMC12832620

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.